Browsing: 2026 – February

Gilts-based investment approach is feeding through to the prices offered to pension schemes entering BPA transactions by insurers.

The UK’s equity release securitisation market has re-emerged in recent years as a tool in a life insurer’s capital optimisation effort.

Fitch Ratings has a ‘neutral’ outlook for North American life insurers for 2026 despite a more challenging backdrop.

Greg Winterton caught up with Dr. Joshua Funder, CEO and Managing Director of Household Capital, to discuss the current state of and outlook for the reverse mortgage sector of the Australian securitisation market in this month’s Q&A.

€1.3bn longevity swap reinsurance agreement covers a portion of the defined benefit pensions included in a pension buy‑out and marks Pacific Life Re’s second longevity reinsurance transaction in the Netherlands.

The buy-in, covering both pensioners and deferred members, secures the benefits of over 3,600 members, while removing funding and investment risk for the scheme.

£113m bulk purchase annuity full buy-in secures the benefits of all 355 Section members within the scheme.

The deal secures the pension benefits of over 3,000 members of the Avon Cosmetics Pension Plan.

The deal secures the pension benefits of over 3,000 members of the Senior plc Pension Plan.

Longevity and Mortality Investor’s Editor’s Letter for the February 2026 issue.